Latham & Watkins Advises on US$5.4 Billion Acquisition of Wright Medical by Stryker

An Orange County-based corporate team advised the financial advisors in the transaction.

November 04, 2019

Wright Medical Group N.V. has announced that it has entered into a definitive agreement under which Stryker Corporation will acquire all of the issued and outstanding ordinary shares of Wright for total enterprise value of approximately US$5.4 billion. The acquisition is expected to close in the second half of 2020 subject to receipt of applicable regulatory approvals, the adoption of certain resolutions relating to the transaction at an extraordinary general meeting of Wright’s shareholders, completion of the tender offer and other customary closing conditions. 

Latham & Watkins LLP represents the financial advisors, Guggenheim Securities, LLC and J.P. Morgan Securities LLC, to Wright in the transaction with a corporate team led by Orange County partner Charles Ruck with associate Brian Umanoff. Advice was also provided on compliance matters by Orange County partner Michele Johnson and on competition matters by Washington, D.C. partner Mandy Reeves.

 

 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.